There were only two previous studies conducted in Egypt to assess the role of PTEN in CRC patients, and they concluded that PTEN loss may be linked to a lower chance of a favorable result for CRC patients and may potentially be associated with the formation of CRC. This evidence concerns the gene PTEN and colorectal carcinoma.